- Home
- NVEE vs NEO Comparison
NVEE vs NEO Comparison
Compare NVEE & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVEE
- NEO
- Stock Information
- Founded
- NVEE 1949
- NEO 2001
- Country
- NVEE United States
- NEO United States
- Employees
- NVEE N/A
- NEO N/A
- Industry
- NVEE Other Consumer Services
- NEO Precision Instruments
- Sector
- NVEE Consumer Discretionary
- NEO Health Care
- Exchange
- NVEE Nasdaq
- NEO Nasdaq
- Market Cap
- NVEE 1.0B
- NEO 965.2M
- IPO Year
- NVEE 2013
- NEO 1999
- Fundamental
- Price
- NVEE $22.26
- NEO $7.48
- Analyst Decision
- NVEE Buy
- NEO Buy
- Analyst Count
- NVEE 4
- NEO 9
- Target Price
- NVEE $25.67
- NEO $13.31
- AVG Volume (30 Days)
- NVEE 850.4K
- NEO 1.5M
- Earning Date
- NVEE 05-01-2025
- NEO 07-28-2025
- Dividend Yield
- NVEE N/A
- NEO N/A
- EPS Growth
- NVEE N/A
- NEO N/A
- EPS
- NVEE 0.45
- NEO N/A
- Revenue
- NVEE $962,752,000.00
- NEO $672,361,000.00
- Revenue This Year
- NVEE $11.23
- NEO $13.86
- Revenue Next Year
- NVEE $5.16
- NEO $11.38
- P/E Ratio
- NVEE $49.29
- NEO N/A
- Revenue Growth
- NVEE 8.74
- NEO 10.10
- 52 Week Low
- NVEE $14.75
- NEO $6.08
- 52 Week High
- NVEE $26.14
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- NVEE 69.42
- NEO 42.80
- Support Level
- NVEE $21.92
- NEO $7.02
- Resistance Level
- NVEE $22.50
- NEO $7.63
- Average True Range (ATR)
- NVEE 0.56
- NEO 0.37
- MACD
- NVEE -0.03
- NEO 0.02
- Stochastic Oscillator
- NVEE 90.84
- NEO 31.29
About NVEE NV5 Global Inc.
NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.